Search for: "Pharmaceutical Associates, Inc." Results 561 - 580 of 1,890
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v… [read post]
21 Nov 2012, 5:00 am by Bexis
  The plaintiff in Miller, therefore, tried to distinguish the case from those involving oral-dose formulations, which really just take issue with inherent risks associated with the API. [read post]
20 Aug 2021, 12:15 pm by Tom Lamb
In April 2013 a so-called “Dear Doctor” letter was sent out in Canada by Novartis Pharmaceuticals Canada Inc. warning about some serious side effects associated with Tasigna and a drug label change with new information concerning those leukemia drug Tasigna side effects. [read post]
29 Aug 2014, 7:30 am
Readers may still be looking forward to a ruling from the Court of Justice of the European Union (CJEU) in Case C-661/13 Astellas Pharma Inc. v Polpharma SA Pharmaceutical Works, which was excitedly publicised by this Kat here and here on account of its potential for clarifying the scope of Bolar exemptions from patent infringement in favour of experimental use. [read post]
25 May 2010, 7:54 am by Ed Wallis
” As a result, “Ortho-McNeil Pharmaceutical LLC will pay a $6.14 million criminal fine after pleading guilty…to one count of misdemeanor violation of the Food, Drug and Cosmetic Act for promoting Topamax for unproved uses,” while “its holding company, Titusville, NJ-based Ortho-McNeil-Janssen Pharmaceuticals Inc., will pay $75.37 million to resolve civil allegations under the False Claims Act. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
11 May 2012, 8:28 am by Joshua Matz
Levine and PLIVA Inc. v. [read post]
23 May 2022, 8:02 am by admin
Kelly and two of his former associates go on trial in Chicago, the sparks are starting to fly. [read post]
27 Jun 2011, 8:41 am by Kali Borkoski
Amicus brief of Mylan Pharmaceuticals, Inc. [read post]
14 Feb 2019, 2:00 am by Tinker Ready
” A brief in support of the limits was filed by industry groups, including the Pharmaceutical Research and Manufacturers of America and the National Association of Manufacturers, with the Chamber of Commerce. [read post]